Digimarc earnings beat by $0.19, revenue fell short of estimates

Digimarc (DMRC) reported Q3 EPS of -$0.13, beating estimates by $0.19, but revenue of $6.44M missed expectations of $7.14M. The stock is down 1.33% over 3 months and 5.47% over 12 months. InvestingPro rates its financial health as 'fair performance'.

Original reporting
Published Nov 12, 2026, 9:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$DMRC
Neutral
medium confidence
Mentioned
$DMRC
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$DMRCNeutralMed
01

Why it matters

The mixed earnings may lead to short‑term price pressure, though the EPS beat provides some support.

02

Market read

Micro‑cap earnings release with modest trading relevance for short‑term traders.

03

What to watch

Potential upcoming contracts or licensing deals not disclosed in this release could offset the revenue shortfall.

Relevance 6/10Novelty 7/10Timing: after‑hours release

Background

Digimarc (NASDAQ: DMRC) reported its third‑quarter results, highlighting an EPS beat but revenue miss.

Company-level read

Ticker impact

$DMRCNeutralMedium confidence
Context

Q3 EPS of $-0.130 beat estimate by $0.19, while revenue of $6.44M fell short of the $7.14M consensus.

Expected impact

modest downside as investors weigh revenue shortfall against EPS beat

Evidence & confidence

Micro‑cap earnings often trigger short‑term moves; the mixed result suggests limited upside and possible sell‑off.

Market effects

Small impact on the digital watermarking and data‑security niche; peers may see similar scrutiny on revenue growth.

Limited to U.S. micro‑cap investors; no broader regional effect.

Low global relevance given the company's size and niche market.

Counterpoint

Revenue miss could be a buying opportunity if the market overreacts to a single quarter.

Key entities

  • Digimarc

    Provider of digital watermarking and data‑security solutions.

Related articles

$DMRCMed

Digimarc Reports Third Quarter 2026 Financial Results

Digimarc Corp (DMRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Digimarc Reports Third Quarter 2026 Financial Results Narrowing our Aperture to Accelerate Beaverton, Ore. – November 12, 2026 – D igimarc Corporation (NASDAQ: DMRC) reported financial results for the third quarter ended September 30, 2026 . "Last quarter we said our

$DMRCMed

Digimarc Reports Second Quarter 2026 Financial Results

Digimarc Corp (DMRC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Digimarc Reports Second Quarter 2026 Financial Results Narrowing our Aperture to Accelerate Beaverton, Ore. – August 13, 2026 – D igimarc Corporation (NASDAQ: DMRC) reported financial results for the second quarter ended June 30, 2026 . "We are already starting to se

$NOKMed

LightCounting:: November 2026 Nokia SReXperts

Nokia hosted its SReXperts/Wavelengths conference in November 2026, focusing on AI's impact on connectivity and its solutions for customers. The company reported strong Q3 2026 earnings, with AI & Cloud sales doubling year-over-year and $1.7 billion in new orders. Nokia expects 25-30% growth in its Optical and IP Networks businesses in 2027. The company aims to help telecom operators adapt to AI-driven changes and capitalize on new opportunities.

$IBRXLow

IBRX Stock Eyes Best Year Ever: Founder Teases 12 Months Of ‘Stealth’ NantWorks Reveals — Cancer Tech, AI Chips And Satellites

ImmunityBio (IBRX) reported a 53% increase in Q3 net product revenue to $48.7M, with 92% growth for the first nine months. The company is testing its drug Anktiva for sepsis and aims to expand FDA approval for bladder cancer. NantWorks, led by Patrick Soon-Shiong, plans a blockchain-based exchange for tokenized securities. IBRX stock has risen 195% over the past year, with bullish retail sentiment on Stocktwits.